https://www.reuters.com/business/healthcare-pharmaceuticals/immunitybio-slumps-fda-declines-approve-bladder-cancer-treatment-2023-05-11/
0
0
5/11/23 at 2:34pm
Organization
Reuters
Authors
ImmunityBio Inc <a href="https://www.reuters.com/companies/IBRX.O" target="_blank">(IBRX.O)</a> said on Thursday the U.S. Food and Drug Administration has declined to approve its combination therapy to treat a type of bladder cancer due to deficiencies in the…
Create an account
or login to join the discussion